Yi Yang

Yi Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2021 in Journal of Ginseng Research
Verified
Journal Article
Open access
YYYi Yang
Yi Yang
HWHong Wang
Hong Wang
MZMing Zhang
Ming Zhang
MSMengxue Shi
Mengxue Shi
CYCailing Yang
Cailing Yang
ZLZhi Li
Zhi Li
In physical activity or labor, the human body is in a state of high intensity stress, and all parts or physiological functions of the body respond positively to maintain or balance the need for movement. The human body has many physiological changes in the process of movement, and fatigue is the external manifestation of various complex changes inside the human body. Fatigue is also a physiological mechanism of self-protection after the body reaches a certain level of activity, which can prevent the occurrence of life-threatening excessive functional failure. The generation of fatigue is a very complex process, and its mechanism has not been concluded yet. Therefore, it is an important work to search and screen the effective components of natural plants that have anti-fatigue effect and to explore their mechanism. This was a 8-week, randomized, double-blind, placebo-controlled clinical trial. A total of 110 subjects who passed physical examination were included according to the scheme design, and randomly divided into a test group which was given KRG and a placebo control group. The calculation is carried out according to the standard of sub-high-intensity exercise test. There was no adverse effect on safety index of subjects after taking red ginseng capsule. After KRG treatment, subjective strength grade is significant lower than placebo treatment. Blood lactic acid content is significantly get lower after trial in KRG group, and significant lower than placebo group. Creatine phosphokinase(CK) content is significantly get lower after trial in KRG group, and significant lower than placebo group. According to the criterion in the test scheme, the result shows that KRG is helpful on relieving physical fatigue.

31 May 2024 in Journal of Ginseng Research
Verified
Journal Article
Open access
YYYi Yang
Yi Yang
JLJing Li
Jing Li
SZShengyuan Zhou
Shengyuan Zhou
DNDaoyan Ni
Daoyan Ni
CYCailing Yang
Cailing Yang
NWNa Wang
Na Wang
As a physiological function of body, immunity can maintain health by identifying itself and excluding others. With economic development and increasingly fierce social competition, the number of sub-healthy population is gradually increasing, and the most basic problem exposed is human hypoimmunity. Hypoimmunity can be manifested as often feeling tired, catching colds, mental depression, etc. In order to enhance immunity, eating healthy foods with the effect of enhancing immunity may become an effective choice. KRG has pharmacological effects of enhancing immunity. Because the screening and evaluation method of immune population are not unified, there are relatively few KRG immunity tests for sub-health population. It is of great significance to study the effect of KRG on people with hypoimmunity to improve sub-health status. This was a 180-day, randomized, double-blind, placebo-controlled clinical trial. According to the trial scheme design, 119 qualified subjects were included and randomly divided into the test group taking KRG and the placebo control group. Subjects need to check safety indicators (blood pressure and heart rate, blood routine, liver and kidney function, urine routine and stool routine) and efficacy indicators (main and secondary) inspection at baseline, efficacy indicators inspection during the mid-term of the test (90th days of administration), safety and efficacy indicators inspection after the test (180th days of administration). After the test, the safety indicators of placebo control group and KRG test group were basically within the normal range, and there is no significant difference in fireness score between the two groups. Through follow-up interviews, it was found that the subjects in the test group and the control group had no adverse reactions and allergic reactions such as nausea, flatulence, diarrhea, and abdominal pain during the test period. Self-comparison of the test group, the results of the main efficacy indicators: (1) immune related health scores were significantly improved in the mid-term and after the test (P < 0.01), (2) CD3 and CD4/CD8 increased significantly after the test (P < 0.05), (3) IgG, IgA, IgM and WBC increased significantly in the mid-term and after the test (P < 0.01); the results of the secondary efficacy indicators: (1) TNF-α decreased significantly in the mid-term (P < 0.05), IFN-γ decreased significantly in the mid-term (P < 0.01), (2) NK increased significantly in the mid-term and after the test (P < 0.05), (3) monocyte increased significantly in the mid-term and after the test (P < 0.01). Inter-group comparison of the test group and the control group, the results of the main efficacy indicators: (1) immune related health scores were higher than that of the control group in the mid-term and after the test (P < 0.01), (2) IgA of the test group was higher than that of the control group in the mid-term and after the test (P < 0.05); the results of the secondary efficacy indicators: (1) WBC of the test group was higher than that of the control group in the mid-term (P < 0.05); (2) monocytes of the test group were higher than that of the control group in the mid-term and after the test (P < 0.05), neutrophils of the test group were higher than that of the control group in the mid-term (P < 0.05). Taking KRG has no adverse effects on the health of the subjects. According to the standard of clinical trial scheme, the immune related health scores and IgA in the main efficacy indicators were positive, which shows that KRG is helpful in enhancing human immunity.

7 February 2025 in Medicine
Verified
Journal Article
Open access
MLMei-Yu Lv
Mei-Yu Lv
YYYi Yang
Yi Yang
WFWenting Fei
Wenting Fei
JLJin-Lian Liu
Jin-Lian Liu
RZRui Zhang
Rui Zhang
JZJian-jun ZHANG
Jian-jun ZHANG
Background: Traditional Chinese Medicine categorizes melasma into various syndromes, one of which is the kidney-deficiency and blood-stasis syndrome. Different Chinese medicines are used for each syndrome to achieve a personalized treatment approach, resulting in a more effective outcome. The study aimed to investigate the efficacy and safety of Lutai Danshen Baishao Granules (LDBG) in alleviating melasma and to compare the effects of LDBG in patients with and without kidney-deficiency and blood-stasis syndrome through a real-world, large-sample investigation. Methods: A multicenter, prospective, nonrandomized, observational trial was conducted from December 2021 to May 2023, recruiting 1000 female participants with melasma. After enrollment, participants were divided into Group A (kidney-deficiency and blood-stasis syndrome) and group B (non-kidney-deficiency and blood-stasis syndrome) based on the traditional Chinese medicine (TCM) syndrome scale. General physical signs, melasma indicators, Dermatology Life Quality Index, and TCM syndrome scores were recorded before and after the intervention. The long-term effectiveness was assessed 2 months after the intervention ended. Results: Following the intervention, melasma-related indicators and TCM syndrome scores were significantly lower than those before the intervention (P < .001). Compared to Group B, Group A showed a more significant reduction in the total area of melasma and the Melasma Area and Severity Index score (P < .05). The reduction in melasma area was also more pronounced in Group A (group A: 425.00 vs group B: 312.50, P < .001). Two months after the intervention, intergroup and intragroup comparisons revealed that LDBG had a long-term effect with a lower tendency for recurrence, and the long-term effect in Group A was better than in group B (P < .05). The overall incidence of adverse events during the trial was 1.2%. Conclusion: LDBG can reduce facial melasma and improve TCM syndromes, particularly in cases of melasma associated with kidney-deficiency and blood-stasis syndrome, with high safety and low risk of relapse.

23 September 2022 in Medicine
Verified
Journal Article
Open access
WFWenting Fei
Wenting Fei
JZJianjun Zhang
Jianjun Zhang
LWLin-yuan Wang
Lin-yuan Wang
YYYi Yang
Yi Yang
YCYan Chen
Yan Chen
YZYingli Zhu
Yingli Zhu
Introduction: Functional constipation (FC) is a common functional gastrointestinal disease and is one of the most common outpatient diseases. The purpose of this study was to investigate the efficacy and safety of the traditional Chinese medicine Besunyen Detox Tea (BDT) for FC and to compare the effect of BDT between constipation patients with and non-dryness-heat syndrome. Methods and analysis: This multicenter, prospective, observational registry study included 1000 participants diagnosed with FC. This study will collaborate with 3 comprehensive hospitals and 15 community hospitals and recruit patients into the registry between July 2022 and July 2023. After enrollment, we will collect the individual characteristics of each patient, anthropometric data and general condition, bowel movement, patient assessment of constipation symptoms, patient assessment of constipation quality of life, TCM syndrome scale, and time to take the laxative product again after treatment. We will also record adverse events and economic indicators at each visit. Discussion: This is the first registry-based study to collect real-world data of participants diagnosed with FC receiving BDT treatment. The results of this registry may also reflect these characteristics and provide direct clinical evidence to verify the importance of syndrome differentiation and treatment for the use of TCM health care products.

8 November 2025 in Journal of Ginseng Research
Verified
Journal Article
Open access
GTGuijun Tan
Guijun Tan
LZLi Zhang
Li Zhang
ZZZihan Zhao
Zihan Zhao
XZXu Zhang
Xu Zhang
NWNa Wang
Na Wang
YYYi Yang
Yi Yang
This study aimed to evaluate the clinical efficacy and safety of Korean red ginseng through a randomized controlled trial and explore the potential targets and pathways for Korean red ginseng to exert clinical efficacy by combining network pharmacology and clinical trial results. We included randomly allocated participants to a test group that received red ginseng or a placebo control group. Network pharmacology was used to analyze the targets of Korean red ginseng and the genes related to type II diabetes, with the core targets being inferred. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were conducted to explore the potential mechanisms of action of red ginseng. Regarding safety, none of the participants showed adverse effects. The test group exhibited significant post-intervention reductions in fasting blood glucose (from 6.44 ± 1.17 to 6.19 ± 1.14 mmol/L), 2-h blood glucose (from 11.96 ± 4.40 to 10.48 ± 3.72 mmol/L), and HbA1c (from 6.27 ± 0.79 to 6.12 ± 0.81 %; all P < 0.01). Immune markers, including CD4/CD8, IgG, IgA, and IgM, remained within normal limits in both groups. Further hierarchical analysis revealed that red ginseng significantly increased IgA levels and natural killer cells in patients with type 2 diabetes with low immunity, with a significant between-group difference. Network pharmacology identified effective components of Korean red ginseng for treating type II diabetes, including ginsenoside Rb1, ginsenoside-Rg3, and Ginsenoside Rb2, with potential targets such as toll-like receptors 2 and 4, tumor necrosis factor, etc. According to the Evaluation Method of Auxiliary Blood Glucose Lowering Function of health products (2012 Version), we can conclude that RG capsules can help reduce blood glucose levels in individuals with Type 2 diabetes and Impaired Glucose Regulation.

13 December 2025 in Journal of Ginseng Research
Verified
Journal Article
Open access
XWXueYing Wang
XueYing Wang
YYYi Yang
Yi Yang
TZTianYu Zheng
TianYu Zheng
CWChengZhi Wang
ChengZhi Wang
SQSiYu Qu
SiYu Qu
YLYanLing Li
YanLing Li
Menopause involves both physical and psychological changes, notably vasomotor and mood symptoms. Menopausal symptoms adversely affect women's quality of life and work. This study evaluates the effects of red ginseng beverage (RGB) on menopausal symptoms in Chinese women. This 90-day, randomized, double-blind, placebo-controlled trial involved 112 eligible women assigned to either an RGB or placebo group. Primary outcomes were the Kupperman Index. Secondary outcomes included vasomotor markers, psychological assessments, lipid profiles, exercise-induced fatigue test indicators and safety indicators. Safety assessments included fire-heat symptom scale, female hormone levels, endometrial thickness, breast ultrasound, and standard laboratory tests. All outcomes were assessed at baseline and upon study completion. RGB group primary outcomes compared to placebo: (1) the Kupperman Index (KI) scores were significantly improved after test (p < 0.001), (2) the levels of serum nitric oxide (NO) increased significantly (p < 0.01), the content of and endothelin-1 (ET-1) decreased significantly (p < 0.01); the results of the secondary outcomes in RGB group: (1) Beck Depression Inventory (BDI) and Athens Insomnia Scale (AIS) scores decreased significantly (p < 0.001), (2) Total cholesterol and low-density lipoprotein cholesterol decreased significantly (p < 0.05), (3) Creatine kinase and blood lactate decreased significantly (p < 0.05), subjective physical strength rating scale scores decreased significantly (p < 0.01). No intergroup differences were observed in hormonal levels, endometrial thickness, urinalysis, hematology, or biochemistry. RGB administration showed no significant effect on fire-heat symptom scores. These findings demonstrate RGB's efficacy and safety for menopausal symptom management.